DOCSLIB.ORG

Top Prescription Drugs Older Adults Should Avoid Page 1 of 2

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Top Prescription Drugs Older Adults Should Avoid Page 1 of 2 Top Prescription Drugs Older Adults Should Avoid page 1 of 2 Drug Problem Pain relievers amitriptyline (elavil) Amitriptyline can cause dry mouth, constipation, drowsiness, confusion and even hallucinations. indomethacin (indocin) Of all nonsteroidal anti-inflammatory drugs, indomethacin affects the brain the most. It can cause confusion or dizziness. narcotics Propoxyphene (Darvon) These are all opioids. Any opioid can cause constipation, urinary and combination products retention, drowsiness and confusion. However, those listed here that includes it (Darvocet-n) are particularly problematic. Propoxyphene, the main ingredient in Darvon and Darvocet, provides no more pain relief than acetaminophen. It may interfere with sleep and cause confusion. meperidine (Demerol) Meperidine lowers the seizure threshold in older adults, particularly those with renal insufficiency. It may be more likely to cause confusion than other narcotics. Pentazocine (talwin) Pentazocine is more likely to cause confusion and hallucinations than other opioids. antiDePressants Fluoxetine (Prozac) Fluoxetine’s effect lasts a long time. It may cause sleep taken daily disturbances, restlessness and increased agitation. It also may decrease appetite in some older adults who do not need to lose weight. If used, consider once weekly dosing. Doxepin (sinequan) Used to treat depression or sleep. These medications can amitriptyline (elavil) cause sedation, weakness, blood pressure changes, dry mouth, problems with urination, and can lead to falls and fractures. These are rarely the drugs of choice for older adults. clevelandclinic.org/geriatrics 10-GER-004 Top Prescription Drugs Older Adults Should Avoid page 2 of 2 Drug Problem sleeP anD anti-anxiety meDications benzodiazepines (long-acting): The effect of these medications last a long time (often days) Flurazepam (Dalmane) producing prolonged sedation and increasing the incidence of falls Diazepam (valium) and fractures. chlordiazepoxide (librium) Quazepam (Doral) clorazepate (tranxene) Heart meDications Digoxin Because aging kidneys cannot excrete this drug well, doses in older adults should rarely exceed 0.125 mg daily. Adverse effects include poor appetite, nausea, weight loss, confusion, and sometimes hallucinations, even when levels appear therapeutic. amiodarone Used to treat abnormal heart rhythms (arrythmias). This drug can cause thyroid, lung and liver problems in any person. Older adults may develop additional adverse effects, including gait abnormalities, depression, difficulty concentrating and confusion. This is not a good choice for an atrial arrhythmia such as atrial fibrillation unless all other drugs have been tried first. methyldopa (aldomet) May slow the heart rate and worsen depression. Diabetes meDications chlorpropamide (Diabinase) This drug’s effects last a long time. In older adults, chlorpropamide can lower blood sugar levels for several hours. This drug also can lower the serum sodium in the blood. A low sodium level can lead to changes in personality, confusion and sluggishness. clevelandclinic.org/geriatrics 10-GER-004 Top Over-the-Counter Drugs Older Adults Should Avoid page 1 of 2 Drug Problem stomacH anD intestinal meDications cimetidine (tagamet) Used to treat heartburn, indigestion or ulcers. Typical doses of cimeti- dine may have side effects, especially confusion. mineral oil Used to treat constipation. There is potential for aspiration and adverse effects. Safer alternatives are available. stimulant laxatives: Used to treat constipation. May be acceptable to use if patient also is bisacodyl (Dulcolax) taking opiate analgesics. Long-term use may cause bowel dysfunction. cascara sagrada allergies Diphenhydramine May cause confusion and sedation. Should not be used to aid sleep. (benadryl) Consider use of non-sedating antihistamines like loratadine as an alter- native. If diphenhydramine is used to treat emergency allergic reactions, it should be used at the smallest dose possible. insomnia Diphenhydramine (compoz Aids containing diphenhydramine may cause confusion, blurred vision, nighttime sleep aid, dry mouth, urinary retention or incontinence, and sedation. Consider sominex maximum strength, melatonin containing products, wearing amber-colored glasses for two sominex nighttime sleep hours prior to bedtime, chamomile tea, soft music, and/or a warm bath aid, unisom sleepgels, before bedtime instead. bayer Pm, excedrin Pm, tylenol Pm) anemia Ferrous sulfate in doses Used to treat iron deficiency anemia. Doses greater than 325 mg per greater than 325 mg day do not dramatically increase the amount absorbed but greatly worsen constipation. clevelandclinic.org/geriatrics 10-GER-004 Top Over-the-Counter Drugs Older Adults Should Avoid page 2 of 2 Drug Problem colD meDications combination Products: Most of these products contain antihistamines and decongestants, aleve cold and sinus, which may cause confusion, increased blood pressure, urinary inconti- alka-seltzer Plus cold nence or retention, and sedation. Recommend discussing with physician and sinus, Dimetapp cold before using. Also, some products contain alcohol and sugar sweeten- and Fever, robitussin ers, which may interact with prescription drugs. cold severe congestion, sudafed cold and sinus, theraFlu severe cold and congestion oral decongestants: Avoid with high blood pressure, dementia, diabetes, history of heart Pseudoephedrine attack or stroke, or impaired kidney function. (sudafed, Drixoral 12-Hour non-Drowsy) vitamins vitamin a Because vitamin A is stored in the body, high doses of it can lead to toxic syndrome. The incidence of vitamin A toxicity is increasing because of publicity regarding the potential benefits in cancer, skin disorders and wound healing. Monitor for headache, double vision, nausea, vertigo, fatigue or drowsiness. It is not recommended to take doses above the daily recommended intake from multivitamins and dietary supplements. Also, intake of beta-carotene (a vitamin A product) has been linked to increased risk for lung cancer in smokers. vitamin e Vitamin E doses equal or greater than 400 units in older adults with chronic illnesses are associated with an increased risk of death. clevelandclinic.org/geriatrics 10-GER-004.
Load more

Recommended publications
  • Get to the Heart of Pain Relief
    Get to the heart of pain relief Explain why analgesic choice matters to patients with, or at risk for, cardiovascular disease Counseling tips | Dosage | Savings Analgesic considerations that matter to the heart Reinforce your TYLENOL® recommendation to patients with, or at risk for, cardiovascular disease with these counseling tips: TYLENOL® won’t increase the risk of heart attack, heart failure, or stroke the way ibuprofen or naproxen sodium can1 TYLENOL® won’t interfere with aspirin heart therapy the way ibuprofen can2 TYLENOL® won’t increase blood pressure like NSAIDs sometimes can3,4 TYLENOL® won’t interfere with certain high blood pressure medications, such as diuretics and ACE inhibitors, the way NSAIDs sometimes can3,4 Order patient education, samples, and coupons at TylenolProfessional.com Not a member? Register today! The efficacy and safety of TYLENOL® at 4000 mg/day are well established. Healthcare professionals may exercise their discretion and recommend up to 4000 mg. Dosage for Adults Recommended dose from your healthcare professional: mg/day TYLENOL® Regular Strength Active ingredient: acetaminophen 325 mg (per tablet) Use only as directed. DOSE & FREQUENCY DAILY LIMIT 2 tablets every 4 to 6 hours Do not take more than 10 tablets while symptoms last in 24 hours, unless directed by your doctor TYLENOL® Extra Strength Active ingredient: acetaminophen 500 mg (per caplet) Use only as directed. DOSE & FREQUENCY DAILY LIMIT 2 caplets every 6 hours while Do not take more than 6 caplets symptoms last in 24 hours, unless directed by your doctor TYLENOL® 8 HR Arthritis Pain Active ingredient: acetaminophen 650 mg (per extended-release caplet) Use only as directed.
    [Show full text]
  • The Pharmacology of Amiodarone and Digoxin As Antiarrhythmic Agents
    Part I Anaesthesia Refresher Course – 2017 University of Cape Town The Pharmacology of Amiodarone and Digoxin as Antiarrhythmic Agents Dr Adri Vorster UCT Department of Anaesthesia & Perioperative Medicine The heart contains pacemaker, conduction and contractile tissue. Cardiac arrhythmias are caused by either enhancement or depression of cardiac action potential generation by pacemaker cells, or by abnormal conduction of the action potential. The pharmacological treatment of arrhythmias aims to achieve restoration of a normal rhythm and rate. The resting membrane potential of myocytes is around -90 mV, with the inside of the membrane more negative than the outside. The main extracellular ions are Na+ and Cl−, with K+ the main intracellular ion. The cardiac action potential involves a change in voltage across the cell membrane of myocytes, caused by movement of charged ions across the membrane. This voltage change is triggered by pacemaker cells. The action potential is divided into 5 phases (figure 1). Phase 0: Rapid depolarisation Duration < 2ms Threshold potential must be reached (-70 mV) for propagation to occur Rapid positive charge achieved as a result of increased Na+ conductance through voltage-gated Na+ channels in the cell membrane Phase 1: Partial repolarisation Closure of Na+ channels K+ channels open and close, resulting in brief outflow of K+ and a more negative membrane potential Phase 2: Plateau Duration up to 150 ms Absolute refractory period – prevents further depolarisation and myocardial tetany Result of Ca++ influx
    [Show full text]
  • TR-348: Alpha-Methyldopa Sesquihydrate (CASRN 41372-08-1)
    NATIONAL TOXICOLOGY PROGRAM Technical Report Series No. 348 TOXICOLOGY AND CARCINOGENESIS STUDIES OF a/pha-METHYLDOPA SESQUIHYDRATE (CAS NO. 41372-08-1) IN F344/N RATS AND B6C3Fi MICE (FEED STUDIES) U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES Public Health Service National Institutes of Health NTP TECHNICAL REPORT ON THE TOXICOLOGY AND CARCINOGENESIS STUDIES OF a/p/)a-METHYLDOPA SESQUIHYDRATE (CAS NO. 41372-08-1) IN F344/N RATS AND B6C3Fi MICE (FEED STUDIES) June K. Dunnick, Ph.D., Chemical Manager NATIONAL TOXICOLOGY PROGRAM P.O. Box 12233 Research Triangle Park, NC 27709 March 1989 NTP TR 348 NIH Publication No. 89-2803 U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES Public Health Service National Institutes of Health NOTE TO THE READER This study was performed under the direction of the K’ational Institute of Environmental Health Sci- ences as a function of the National Toxicology Program. The studies described in this Technical Re- port have been conducted in compliance with NTP chemical health and safety requirements and must meet or exceed all applicable Federal, state, and local health and safety regulations. Animal care and use were in accordance with the U.S. Public Health Service Policy on Humane Care and Use of Ani- mals. All NTP toxicology and carcinogenesis studies are subjected to a data audit before being pre- sented for public peer review. Although every effort is made to prepare the Technical Reports as accurately as possible, mistakes may occur. Readers are requested to identify any mistakes so that corrective action may be taken. Further, anyone who is aware of related ongoing or published studies not mentioned in this report is encouraged to make this information known to the NTP.
    [Show full text]
  • Drugs Inducing Insomnia As an Adverse Effect
    2 Drugs Inducing Insomnia as an Adverse Effect Ntambwe Malangu University of Limpopo, Medunsa Campus, School of Public Health, South Africa 1. Introduction Insomnia is a symptom, not a stand-alone disease. By definition, insomnia is "difficulty initiating or maintaining sleep, or both" or the perception of poor quality sleep (APA, 1994). As an adverse effect of medicines, it has been documented for several drugs. This chapter describes some drugs whose safety profile includes insomnia. In doing so, it discusses the mechanisms through which drug-induced insomnia occurs, the risk factors associated with its occurrence, and ends with some guidance on strategies to prevent and manage drug- induced insomnia. 2. How drugs induce insomnia There are several mechanisms involved in the induction of insomnia by drugs. Some drugs affects sleep negatively when being used, while others affect sleep and lead to insomnia when they are withdrawn. Drugs belonging to the first category include anticonvulsants, some antidepressants, steroids and central nervous stimulant drugs such amphetamine and caffeine. With regard to caffeine, the mechanism by which caffeine is able to promote wakefulness and insomnia has not been fully elucidated (Lieberman, 1992). However, it seems that, at the levels reached during normal consumption, caffeine exerts its action through antagonism of central adenosine receptors; thereby, it reduces physiologic sleepiness and enhances vigilance (Benington et al., 1993; Walsh et al., 1990; Rosenthal et al., 1991; Bonnet and Arand, 1994; Lorist et al., 1994). In contrast to caffeine, methamphetamine and methylphenidate produce wakefulness by increasing dopaminergic and noradrenergic neurotransmission (Gillman and Goodman, 1985). With regard to withdrawal, it may occur in 40% to 100% of patients treated chronically with benzodiazepines, and can persist for days or weeks following discontinuation.
    [Show full text]
  • Tricyclic Antidepressant
    Princess Margaret Hospital for Children Emergency Department Guideline PAEDIATRIC ACUTE CARE GUIDELINE Poisoning – Tricyclic Antidepressant Scope (Staff): All Emergency Department Clinicians Scope (Area): Emergency Department This document should be read in conjunction with this DISCLAIMER http://kidshealthwa.com/about/disclaimer/ Poisoning – Tricyclic Antidepressant This guideline is a general approach to tricyclic antidepressant poisoning. For specific details please contact Poisons Information: 131126 or refer to the Toxicology Handbook. Agents: Amitriptyline Clomipramine Dothiepin Doxepin Imipramine Nortriptyline Trimipramine Background Tricyclic antidepressants (TCAs) act on a variety of receptors whose actions include: Noradrenaline reuptake inhibition Central and peripheral anticholinergic effect Fast sodium channel blockade in the myocardium Peripheral alpha1-adrenergic receptor blockade The life threatening effects of acute tricyclic antidepressant (TCA) overdose are: Rapid onset of coma Seizures Cardiac dysrhythmias Page 1 of 6 Emergency Department Guideline Poisoning – Tricyclic Antidepressant Hypotension and central and peripheral anticholinergic effects may also be seen Risk Assessment Most acute accidental paediatric exposures do not result in life threatening toxicity A 10kg child can develop life threatening poisoning with the ingestion of a single tablet (e.g. 150mg amitriptyline) Patients who ingest a large dose of TCA usually develop evidence of intoxication within 2-4 hours, and always within 6 hours If their is suspicion
    [Show full text]
  • United States Patent (10) Patent No.: US 8,969,514 B2 Shailubhai (45) Date of Patent: Mar
    USOO896.9514B2 (12) United States Patent (10) Patent No.: US 8,969,514 B2 Shailubhai (45) Date of Patent: Mar. 3, 2015 (54) AGONISTS OF GUANYLATECYCLASE 5,879.656 A 3, 1999 Waldman USEFUL FOR THE TREATMENT OF 36; A 6. 3: Watts tal HYPERCHOLESTEROLEMIA, 6,060,037- W - A 5, 2000 Waldmlegand et al. ATHEROSCLEROSIS, CORONARY HEART 6,235,782 B1 5/2001 NEW et al. DISEASE, GALLSTONE, OBESITY AND 7,041,786 B2 * 5/2006 Shailubhai et al. ........... 530.317 OTHER CARDOVASCULAR DISEASES 2002fOO78683 A1 6/2002 Katayama et al. 2002/O12817.6 A1 9/2002 Forssmann et al. (75) Inventor: Kunwar Shailubhai, Audubon, PA (US) 2003,2002/0143015 OO73628 A1 10/20024, 2003 ShaubhaiFryburg et al. 2005, OO16244 A1 1/2005 H 11 (73) Assignee: Synergy Pharmaceuticals, Inc., New 2005, OO32684 A1 2/2005 Syer York, NY (US) 2005/0267.197 A1 12/2005 Berlin 2006, OO86653 A1 4, 2006 St. Germain (*) Notice: Subject to any disclaimer, the term of this 299;s: A. 299; NS et al. patent is extended or adjusted under 35 2008/0137318 A1 6/2008 Rangarajetal.O U.S.C. 154(b) by 742 days. 2008. O151257 A1 6/2008 Yasuda et al. 2012/O196797 A1 8, 2012 Currie et al. (21) Appl. No.: 12/630,654 FOREIGN PATENT DOCUMENTS (22) Filed: Dec. 3, 2009 DE 19744O27 4f1999 (65) Prior Publication Data WO WO-8805306 T 1988 WO WO99,26567 A1 6, 1999 US 2010/O152118A1 Jun. 17, 2010 WO WO-0 125266 A1 4, 2001 WO WO-02062369 A2 8, 2002 Related U.S.
    [Show full text]
  • For Personal Use Only
    SedatiWITH ANTIi ® Dowden Health Media CopyrightFor personal use only Initiate the antipsychotic at a reasonable, not overly high dose, then use a nonantipsychotic to help control insomnia, anxiety, and agitation For mass reproduction, content licensing and permissions contact Dowden Health Media. pSYCHIATRY i PSYCHOTICSon edation is a frequent side effect of antipsychot- ics, especially at relatively high doses. Antipsy- S chotics’ sedative effects can reduce agitation in acute psychosis and promote sleep in insomnia, but Manage, don’t long-term sedation may: • interfere with schizophrenia patients’ efforts to go accept adverse to work or school or engage in normal socialization • prevent improvement from psychosocial training, psychiatric rehabilitation, and other treatments. ‘calming’ eff ect This article discusses how to manage acute psycho- sis without oversedation and ways to address persistent sedation and chronic insomnia with less-sedating anti- Del D. Miller, PharmD, MD Professor of psychiatry psychotics or adjunctive medications. University of Iowa Carver College of Medicine Iowa City Neurobiology or psychopharmacology? Many patients experience only mild, transient som- nolence at the beginning of antipsychotic treatment, and most develop some tolerance to the sedating ef- fects with continued administration. Others may have persistent daytime sedation that interferes with nor- mal functioning. Sedation is especially common in elderly patients re- ceiving antipsychotics. Compared with younger patients, older patients receiving
    [Show full text]
  • The Case of Ketamine Allergy
    CASE REPORT The Case of Ketamine Allergy William Bylund, MD Department of Emergency Medicine, Naval Medical Center Portsmouth, Portsmouth, Virginia Liam Delahanty, MD Maxwell Cooper, MD Section Editor: Rick A. McPheeters, DO Submission history: Submitted April 3, 2017; Revision received June 29, 2017; Accepted July 11, 2017 Electronically published October 3, 2017 Full text available through open access at http://escholarship.org/uc/uciem_cpcem DOI: 10.5811/cpcem.2017.7.34405 Ketamine is often used for pediatric procedural sedation due to low rates of complications, with allergic reactions being rare. Immediately following intramuscular (IM) ketamine administration, a three-year-old female rapidly developed facial edema and diffuse urticarial rash, with associated wheezing and oxygen desaturation. Symptoms resolved following treatment with epinephrine, dexamethasone and diphenhydramine. This case presents a clinical reaction to ketamine consistent with anaphylaxis due to histamine release, but it is uncertain whether this was immunoglobulin E mediated. This is the only case reported to date of allergic reaction to IM ketamine, without co- administration of other agents. [Clin Pract Cases Emerg Med.2017;1(4):323–325.] INTRODUCTION cardiac monitor, end tidal CO2 (ETCO2) and pulse oximetry Ketamine is a common medication, used in isolation as well (POx), in addition to being placed on two liters nasal cannula as with other agents, for pediatric sedation in the emergency (NC). No intravenous (IV) access was obtained prior to sedation. department (ED). It is often turned to because of its efficacy, ease Seventy milligrams (4.4mg/kg) of ketamine was administered IM of use, and favorable safety profile. Common side effects of into the right thigh.
    [Show full text]
  • United States District Court for the Central District Of
    Case 2:18-cv-09655 Document 1 Filed 11/15/18 Page 1 of 38 Page ID #:1 SIMMONS HANLY CONROY LLC 1 Crystal Foley (SBN 224627) 2 [email protected] 100 N. Sepulveda Blvd., Suite 1350 3 Los Angeles, CA 90245 4 Phone: (310) 322-3555 5 Mitchel M. Breit (pro hac vice 6 forthcoming) [email protected] 7 112 Madison Avenue 8 New York, New York 10016-7416 Phone: (212) 784-6400 9 10 Attorneys for Plaintiff 11 12 UNITED STATES DISTRICT COURT FOR THE CENTRAL DISTRICT OF CALIFORNIA 13 WESTERN DIVISION 14 TOYA EDWARDS on behalf of Case No.: ____________________2:18-cv-9655 15 herself and all others similarly 16 situated, Plaintiff, CLASS ACTION COMPLAINT 17 v. 18 DEMAND FOR JURY TRIAL WALMART, INC. 19 20 Defendant. 21 CLASS ACTION COMPLAINT 22 Plaintiff Toya Edwards individually and on behalf of all others similarly 23 situated, brings this action against Defendant Walmart, Inc. (“Walmart”). The 24 following allegations are based upon personal knowledge as to Plaintiff’s own 25 conduct, the investigation of counsel, and upon information and belief as to the acts 26 of others. 27 28 1 CLASS ACTION COMPLAINT Case 2:18-cv-09655 Document 1 Filed 11/15/18 Page 2 of 38 Page ID #:2 1 INTRODUCTION 2 1. Walmart is the world’s largest retail company operating thousands of 3 retail stores worldwide. 4 2. Walmart stores sell all types of products to the American public, 5 including toys, groceries, sports and outdoor equipment, electronics, home goods, 6 school supplies, apparel, cosmetics, health and wellness products, and many more.
    [Show full text]
  • NTP-CERHR Expert Panel Report on the Reproductive and Developmental Toxicity of Amphetamine and Methamphetamine
    Published 2005 Wiley-Liss, Inc.w Birth Defects Research (Part B) 74:471–584 (2005) NTP-CERHR Expert Panel Report on the Reproductive and Developmental Toxicity Of Amphetamine and Methamphetamine Mari Golub,1 Lucio Costa,2 Kevin Crofton,3 Deborah Frank,4 Peter Fried,5 Beth Gladen6 Rogene Henderson,7 Erica Liebelt,8 Shari Lusskin,9 Sue Marty,10 Andrew Rowland11 John Scialli12 and Mary Vore13 1California Environment Protection Agency, Sacramento, California 2University of Washington, Seattle, Washington 3U.S. Environmental Protection Agency, Research Triangle Park, North Carolina 4Boston Medical Center, Boston, Massachusetts 5Carleton University, Ottawa, Ontario 6National Institute of Environmental Health Sciences, Research Triangle Park, North Carolina 7Lovelace Respiratory Research Institute, Albuquerque, New Mexico 8University of Alabama at Birmingham School of Medicine, Birmingham, Alabama 9New York University School of Medicine, New York, New York 10The Dow Chemical Company, Midland, Michigan 11University of New Mexico, Albuquerque, New Mexico 12Phoenix, Arizona 13University of Kentucky, Lexington, Kentucky PREFACE studies indexed before December 31, 2004. References were also identified from databases such as REPRO- The National Toxicology Program (NTP) and the TOXs, HSDB, IRIS, and DART and from report National Institute of Environmental Health Sciences bibliographies. (NIEHS) established the NTP Center for the Evaluation This evaluation resulted from the efforts of a 13- of Risks to Human Reproduction (CERHR) in June 1998. member panel of government and non-government The purpose of the Center is to provide timely, unbiased, scientists that culminated in a public expert panel scientifically sound evaluations of human and experi- meeting held January 10–12, 2005. This report is a mental evidence for adverse effects on reproduction and product of the Expert Panel and is intended to (1) development caused by agents to which humans may be interpret the strength of scientific evidence that exposed.
    [Show full text]
  • Diphenhydramine Dosage Sheet Concord Pediatrics, P.A
    Diphenhydramine Dosage Sheet Concord Pediatrics, P.A. (603) 224-1929 BRAND NAMES: Benadryl INDICATIONS: Treatment of allergic reactions, nasal allergies, hives and itching. FREQUENCY: Repeat every 6 hours as needed. Don't give more than 4 times a day. DOSAGE: Determine by using the table below. Please speak with a medical provider before giving Diphenhydramine to a child under 1 year old. Child’s Dose in mg Children’s Liquid Chewable/Fastmelts Tabs/Caps/Gels Weight (lb) (12.5mg/ 5mL) 12.5mg tablets 25mg tablets *12-16 lbs 6.25 mg 2.5 mL *17-19 lbs 9.375 mg 3.75 mL *20-24 lbs 10 mg 4 mL 25-37 lbs 12.5 mg 5 mL 1 tab 38-49 lbs 18.75 mg 7.5 mL 1.5 tabs 50-69 lbs 25 mg 10 mL 2 tabs 1 tab 70-99 lbs 37.5 mg 15 mL 3 tabs 1.5 tabs >100 lbs 50 mg 20 mL 4 tabs 2 tabs Table Notes: *AGE LIMIT: For allergies, don't use under 1 year of age (Reason: it's a sedative). For colds, not recommended at any age (Reason: no proven benefits) and should be avoided if under 4 years old. Avoid multi-ingredient products in children under 6 years of age (Reason: FDA recommendations 10/2008). MEASURING the DOSAGE: Syringes and droppers are more accurate than teaspoons. If possible, use the syringe or dropper that comes with the medicine. If not, medicine syringes are available at pharmacies. Regular spoons are not reliable. ADULT DOSAGE: 50 mg Why use Diphenhydramine? Antihistamines can be used to treat your child’s runny nose, itchy eyes, and sneezing due to allergies.
    [Show full text]
  • Sleep Inducing Toothpaste Made with Natural Herbs and a Natural Hormone
    Sleep inducing toothpaste made with natural herbs and a natural hormone Abstract A toothpaste composition for inducing sleep while simultaneously promoting intraoral cleanliness, which includes toothpaste base ingredients and at least one sleep- inducing natural herb or hormone. The sleep-inducing natural herbs and hormone are selected from the group consisting of Chamomile, Lemon Balm, Passion Flower, and Valerian, and the hormone Melatonin. The sleep-inducing natural herbs are in a range of 0.25% to 18% by weight of the composition. Description of the Invention FIELD OF THE INVENTION The following natural herbs and natural hormone in combination with toothpaste is used at night to improve sleep. The expected dose of toothpaste is calculated at 2 grams. The ingredients have been assessed for range of daily dose for best effects, toxicity in normal range, recommended proportion of each, and water solubility of key constituents. BACKGROUND OF THE INVENTION It is an object of the present invention to provide a sleep-inducing toothpaste or mouth spray which includes sleep-inducing natural herbs and a natural hormone. It is a further object of the present invention to provide a sleep-inducing toothpaste which includes toothpaste base ingredients and natural herbs being Chamomile, Lemon Balm, Passion Flower, Valerian and the natural hormone Melatonin. SUMMARY OF THE INVENTION A toothpaste composition is provided for inducing sleep while simultaneously promoting intraoral cleanliness, which includes toothpaste base ingredients and at least one sleep-inducing natural herb or hormone. The sleep-inducing natural herbs and hormone are selected from the group consisting of the natural herbs Chamomile, Lemon Balm, Passion Flower, and Valerian, and the natural hormone Melatonin.
    [Show full text]